A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2363-2371

  Sheu, Bor Shyang ^a   Chi, Chih Hsein ^a   Yang, Hsiao Bai ^a   Jen, Chang Min ^a   Lin, Xi Zhang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

24 Hour intragastric pH meter; Duodenal ulcer bleeding; H. pylori; Intravenous omeprazole

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ERYTHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE; SULTAMICILLIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM BLEEDING; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH PH;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; ERYTHROMYCIN; FEMALE; GASTRIC ACIDITY DETERMINATION; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PEPTIC ULCER HEMORRHAGE;

EID: 0032877974     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterol 1989; 96:615-625.
2. Blaser MJ: Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterol 1987; 93:371-383.
3. Peterson WL: Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324:1043-1048.
4. Hentschel E, Brandsttater G, Dragosics B, et al: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328:308-312.
5. Graham DY, Lew GM, Evans DG, Evans DJ Jr, Klein PD: Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 1991; 115:266-269.
6. Graham DY, Lew GM, Klein PD, et al: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer disease. A randomized, controlled study. Ann Intern Med 1992; 116:705-708.
7. Coghlan JG, Gilligan D, Humphries H, et al: Campylobacter pylori and recurrence of duodenal ulcers: A 12 month follow-up study. Lancet 1987; pp. 1109-1111.
8. Labenz J, Borsch G: Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55:19-23.
9. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N: H. pylori eradication reduces the possibility of rebleeding in peptic ulcers. Gastrointest Endosc 1995; 41:1-4.
10. Jespersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH: Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41:5-7.
11. Sheu BS, Yang HB, Su IJ, Shiesh SC, Chi CH, Lin XZ: Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996; 44:683-688.
12. Graham DY: Treatment of peptic ulcer caused by Helicobacter pylori. N Engl J Med 1993; 328:348-350.
13. Graham DY, Lew GM, Malaty HM, et al: Factors influencing the eradication rate of Helicobacter pylori with triple therapy. Gastroenterol 1992; 102:493-496.
14. Sheu BS, Yang HB, Chi CH, Lin XZ: Is severity of H. pylori infection aggravating during H. pylori-related duodenal ulcer bleeding and relevant to the presence of SRH? J Gastroenterol & Hepatol 1996; 11:S1A8. (Abstract)
15. Kiilerich S, Rannem T, Elsborg L: Effects of intravenous infusion of omeprazole and ranitidine on 24 hr intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56:25-30.
16. Brunner GHG, Thiessemann C: The potential clinical role of intravenous omeprazole. Digestion 1992; 51(Suppl 1):17-20.
17. Teyssen S, Chari ST, Scheid J, Singer MV: Effects of repeated boluses of intravenous omeprazole and primed infusions of ranitidines on 24-hour intragastric pH in healthy human subjects. Dig Dis Sci 1995: 40:247-255.
18. van Zanten SJ, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH: Secretion of intravenously administrated antibiotics in gastric juice: implication for Helicobacter pylori. J Clin Pathol 1992; 45:225-227.
19. Lambert J, Cardaci G: Gastric mucosal pharmacology: A rational approach to Helicobacter pylori eradication. J Gastroenterol Hepatol 1995; 10:106-107.
20. Sung JY, Chung SCS, Hosking SW, et al: Short course of Imipenem monotherapy cannot achieve eradication of H. pylori. J Gastroenterol Hepatol 1995; 10:66-69.
21. Adamek RJ, Wegener M: Combined intravenous and oral omeprazole/amoxicillin therapy in patients with H. pylori-positive active peptic ulcer bleeding. Am J Gastroenterol 1993; 88:1980.
22. Adamek RJ, Freitag M, Opferkuch W, Ruhl GH, Wegener M: Intravenous omeprazole/amoxicillin and omeprazole pretreatment in H. pylori positive active ulcer bleeding - a pilot study. Sound J Gastroenterol 1994; 29:880-883.
23. Morshkowitz M, Konikoff FM, Peled Y., et al: High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 1995; 36:845-847.
24. Marshall BJ, Warren JR, Franscis GJ, Langton SR, Goodwin CS, Blincow EW: Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 1987; 82:200-210.
25. Laine L, Peterson W: Current concepts in peptic ulcer bleeding. N Engl J Med 1994; 331:717-727.
26. Chalmhoff C, Creter D, Djaldetti M: The effect of pH on platelet and coagulation factors activities. Am J Surg 1978; 136:257-259.
27. Green FW, Kaplan MM, Curtis LE, Levine PH: Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterol 1978; 74:38-43.
28. Hsu PI, Lai KH, Lin XZ, et al: When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding. Gastrointest Endosc 1996; 44:382-387.
29. Glupczynski Y, Burette A: Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 80:1545-1551.
30. McNulty CAM, Dent JC, Ford GA, Wilkinson SP: Inhibitory concentration against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22:729-738.
31. Malanoshi GJ, Eliopoulos GM, Ferraro MJ, Moellering RC Jr: Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agent and temafloxacin. Eur J Clin Microbiol Infect Dis 1993; 12:131-133.
32. Lambert JR: Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy. Gastroenterol 1996; 107:521-523. (Editorial)
33. Jacqz-Aigrain E, Bellaich M, Faure C, et al: Pharmacokineticss of intravenous omeprazole in children. European J Clin Pharmacology 1994; 47:181-185.
34. Wilder-Smith CH, Merki HS: Antisecretory effects during prolonged infusions of omeprazole and tolerance to ranitidine. Gastroenterol 1993; 104:A224. (Abstract)
35. Wilder-Smith CH, Gwerder C, Hurlimann S, Merki HS: Dosing requirements during omeprazole infusions diminish with time: individually titrated and constant infusions of omeprazole over 48h. Gastroenterol 1993; 104:A223. (Abstract)
36. Andersen J, Strom M, Naesdal J, Leire K, Walan A: Intravenous omeprazole: effect of a loading dose on 24 hr intragastric pH. Aliment Pharmacol Ther 1990; 4:65-72.
37. Lind T, Moore M, Olbe L: Intravenous omeprazole: effect on 24-hour intragastric pH in duodenal ulcer patients. Digestion 1986; 34:78-86.
38. Yang JC, Yang CK, Lin JT, Wang TH: Metronidazole-resistant Helicobacter pylori in the Taiwanese with duodenal ulcer. Chinese J Gastroenterol 1994; 11:253. (Abstract)
39. Goddard AF, Jessa MT, Barett DA, et al: Effect of omeprazole on the distribution of metronidazole, amoxicillin, clarithromycin in human gastric juice. Gastroenterol 1996; 111:358-367.
40. Peters DH, Clissold SP: Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapuetic potential. Drugs 1992; 44:117-164.
41. Chang K, Wyle F, Skankey G, et al: Clarithromycin achieves highest gastric mucosa tissue level among anti-Helicobacter pylori antibiotics. Gastroenterol 1993; 104:A680. (Abstract)